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Background: Though several questionnaires on self-care and regimen adherence have been introduced, the
evaluations do not always report consistent and substantial correlations with measures of glycaemic control. Small
ability to explain variance in HbA1c constitutes a significant limitation of an instrument’s use for scientific purposes
as well as clinical practice. In order to assess self-care activities which can predict glycaemic control, the Diabetes
Self-Management Questionnaire (DSMQ) was designed.
Methods: A 16 item questionnaire to assess self-care activities associated with glycaemic control was developed,
based on theoretical considerations and a process of empirical improvements. Four subscales, ‘Glucose
Management’ (GM), ‘Dietary Control’ (DC), ‘Physical Activity’ (PA), and ‘Health-Care Use’ (HU), as well as a ‘Sum Scale’
(SS) as a global measure of self-care were derived. To evaluate its psychometric quality, 261 patients with type 1 or
2 diabetes were assessed with the DSMQ and an established analogous scale, the Summary of Diabetes Self-Care
Activities Measure (SDSCA). The DSMQ’s item and scale characteristics as well as factorial and convergent validity
were analysed, and its convergence with HbA1c was compared to the SDSCA.
Results: The items showed appropriate characteristics (mean item-total-correlation: 0.46 ± 0.12; mean correlation
with HbA1c: -0.23 ± 0.09). Overall internal consistency (Cronbach’s alpha) was good (0.84), consistencies of the
subscales were acceptable (GM: 0.77; DC: 0.77; PA: 0.76; HU: 0.60). Principal component analysis indicated a four
factor structure and confirmed the designed scale structure. Confirmatory factor analysis indicated appropriate fit of
the four factor model. The DSMQ scales showed significant convergent correlations with their parallel SDSCA scales
(GM: 0.57; DC: 0.52; PA: 0.58; HU: n/a; SS: 0.57) and HbA1c (GM: -0.39; DC: -0.30; PA: -0.15; HU: -0.22; SS: -0.40). All
correlations with HbA1c were significantly stronger than those obtained with the SDSCA.
Conclusions: This study provides preliminary evidence that the DSMQ is a reliable and valid instrument and
enables an efficient assessment of self-care behaviours associated with glycaemic control. The questionnaire should
be valuable for scientific analyses as well as clinical use in both type 1 and type 2 diabetes patients.
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Hyperglycaemia is a major predictor of the development
of diabetes late complications, and improving glycaemic
control has been shown to prevent microvascular as well
as macrovascular events (the latter at least in type 1 dia-
betes) [1-3]. Although a number of internal and external
factors contribute to the level of blood glucose [4], it is
widely accepted that good self-care protects against
complications in both type 1 and type 2 diabetes and
that the patient must actively manage the disease’s re-
quirements in order to achieve optimal blood glucose
outcomes [1,5,6].
It has often been suggested that important psycho-
social factors such as depression and emotional distress
can interfere with self-care behaviours and therefore
negatively impact glycaemic control [7,8]. Consequently,
numerous studies have concentrated on negative emo-
tional conditions and actually found associations with
both reduced self-care activities [9,10] and elevated
HbA1c values [11-15]. However, research has yielded
only limited insight into the suggested behavioural
mechanisms between negative affect and hypergly-
caemia, and this is to be explained at least partially by
methodological problems of construct assessment.
A promising way to study such mechanisms is to util-
ise multiple regression or structural equation modeling
and analyse the putative mediation of the relationship
between an affective condition and HbA1c by self-care.
However, the applicability of this method and the con-
clusiveness of its results strongly depend on the self-care
assessment’s ability to explain variance in the criterion
variable [16]. If the measuring instrument is not suffi-
ciently associated with HbA1c, the putative mediation
may actually not be observed. For example, this may
have been the case with the analysis by Lustman et al.
[17], who found an association between depression and
hyperglycaemia but no mediation of the association by
self-care behaviour.
Taken as a whole, weak associations with glycaemic
outcomes [18-20] or the omission of reporting the crit-
ical data [21,22] can be frequently found among evalua-
tions of eligible questionnaires, but there are also further
obstacles. A recent review of psychometric tools identi-
fied a total of five questionnaires which assess self-
management, but only one fully met the reviewers’ ap-
praisal criteria [23].
That one questionnaire, which satisfied the reviewers’
expectations, was the Summary of Diabetes Self-Care
Activities Measure (SDSCA), which is probably the most
popular and most frequently used instrument in its re-
gard. It has been evaluated in numerous studies, shown
appropriate psychometric qualities and been translated
into many languages. However, the authors stated that
the questionnaire was not conceptualized to be closelylinked to glycated haemoglobin, and consequently, its
initial evaluation did not find any significant associations
between its scales and HbA1c [19]. Later studies have
confirmed this lack of correlation, and to our knowledge
no studies presenting moderate or strong correlations
between the SDSCA and glycated haemoglobin have
been reported [22,24-28].
While a valid assessment of diabetes self-care does not
necessarily need to correlate with glycaemic outcome, a
weak association between an instrument and HbA1c
nevertheless constitutes a major limitation for its use in
research and also for practitioners interested in helping
patients to improve or maintain good glycaemic control.
In order to facilitate the collection of appropriate data,
the Diabetes Self-Management Questionnaire (DSMQ)
was developed. The questionnaire was designed to assess
self-care behaviours which can be related to the measure
of HbA1c, so that the data are suitable for mediational
analyses. A second objective was to construct a brief in-
strument suitable for studies involving a multitude of
data collection instruments including clinical trials. This
article describes the DSMQ’s development and presents
its first psychometric evaluation.
Methods
Two studies were conducted at the German Diabetes
Center Mergentheim (GDCM), a tertiary referral centre
for diabetes (Patients may be referred to the centre for
different reasons. Providing intensive diabetes education,
treating substantial problems of diabetes control, or
performing major changes regarding a patient’s therapy
may be typical reasons for referral. The average time of
the stay is about 10 days.). Study 1 evaluated an initial
set of 37 items on 110 in-patients, resulting in a final
questionnaire containing 16 items. Study 2 assessed the
psychometric properties of this 16-item scale on 261 in-
patients.
Study participation was limited to patients with type 1
or 2 diabetes, adult age, sufficient German language
skills, and providing informed consent. In-patients who
met inclusion criteria were informed about the possibil-
ity to participate in a cross-sectional study of question-
naire evaluation. Patients who consented were assessed
with the DSMQ and the SDSCA. Additionally, demo-
graphic and diabetes-specific characteristics were gained
from the electronic patient records (sex, age, BMI, dia-
betes type, diabetes duration, type of diabetes treatment,
late complication status, and current HbA1c). Both study
samples reflected the typical clinic population compos-
ition, which mainly comprises of type 1 and type 2 dia-
betes in approximately equal percentages as well.
Data collection was carried out during a supplementary
cross-sectional survey of the DIAMOS study (‘Strengthen-
ing Diabetes Motivation’) (Identifier: NCT01009138),
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Chamber of Baden-Wuerttemberg (file number 2009-034
-f). Written informed consent was obtained before
participation.
Instruments and measures
Development of the Diabetes Self-Management
Questionnaire (DSMQ)
The DSMQ was developed at the Research Institute of
the Diabetes Academy Mergentheim. It is the first Ger-
man instrument targeting diabetes self-care, and was
designed to assess behaviours associated with metabolic
control within common treatment regimens for type 1
and type 2 diabetes in adult patients.
Initially, 37 items were generated with contents which,
in view of the literature, were regarded as confirmed or
promising predictors of glycaemic control. In this regard,
the accuracy of medication intake and diet adjustment
were regarded as important predictors in both type 1
and 2 diabetes. Poor adherence to insulin as well as oral
medical regimens has been consistently associated with
hyperglycaemia [29-33], and the change to a diet with a
lower glycaemic index has shown the potential of im-
proving glycaemic control regardless of diabetes type
[34,35].
Another content of interest is self-monitoring of blood
glucose (SMBG) as its impact on glycaemic control is well-
established in type 1 as well as type 2 diabetes with insulin
treatment [36,37]. Although there is uncertainty and de-
bate about its benefit in insulin-naive patients [38], several
studies suggest SMBG can be also advantageous in those
[39-41], particularly when the feedback leads to relevant
action [42]. Furthermore, two recent publications compar-
ably concluded that SMBG can very well be an effective
means of glycaemic control in insulin-naive patients if used
in a structured and knowledgeable way [43,44].
Physical exercise as a means of metabolic control is
commonly used in type 2 diabetes, and its effectiveness
is well established [45,46]. Nevertheless, a recent meta-
analysis found that exercise is also effective in improving
HbA1c levels in type 1 diabetes [47]. Therefore, physical
activity (particularly with regard to diabetes treatment)
was regarded as appropriate item content.
Finally, some items were designed to assess the pa-
tient’s adherence to (vs. avoidance of) appointments with
health-care professionals, which, compared to previous
questionnaires, is a somewhat new aspect. However, a
higher frequency of primary care contacts is associated
with a better glycaemic outcome [48], and the com-
monly motivating effect of feedback on HbA1c is one pu-
tative explanation of this finding [49]. Furthermore,
appointment adherence was found to predict glycaemic
control independently of visit frequency [50,51]. Finally,
appointment adherence seems to be reduced indepressed diabetes patients [9]. Therefore, this aspect
should not be missed out when studying psychosocial
predictors of diabetes control.
The final set of items tested in study 1 comprised of the
following contents: Regularity of medication intake (4
items), diabetes-related aspects of diet (e. g. frequent con-
sumption of foods complicating glycaemic control, adher-
ence to dietary recommendations, alcohol consumption; 8
items), regularity of self-monitoring of blood glucose (4
items), regularity of physical activity (5 items), appoint-
ment adherence (4 items), several specific self-care activ-
ities, e. g. carriage of needed therapy devices, adequate
treatment of hypoglycaemic/ hyperglycaemic episodes,
record of blood glucose levels (5 items), and overall judge-
ments of the adequacy of self-care (7 items). The items
then were reviewed by a team of five psychologists, three
diabetologists, and a sample of 15 diabetes patients, lead-
ing to the final item formulation.
All items were formulated as behavioural descriptions
taking the first person view. Respondents are asked to
rate the extent to which each statement applies to the
personal self-management with regard to the previous
eight weeks. The time frame was chosen in view of the
specific time-dependence of HbA1c values [52,53], as
recommended by Johnson [4]. The rating scale was
designed as a four-point Likert scale (in order to avoid a
neutral response option and force a specific response)
with the response options ‘applies to me very much’
(three points), ‘applies to me to a considerable degree’
(two points), ‘applies to me to some degree’ (one point),
and ‘does not apply to me’ (zero points). The responses
were converted such that higher scores are indicative of
more effective self-care. To enable individual adjustment
in items which assess aspects of SMBG or medical treat-
ment, boxes offering to tick ‘is not required as a part of
my treatment’ were added.
Analysis of responses as part of study 1 led to the
identification of 16 items which formed the final scale
for full psychometric assessment. Seven of these items
are formulated positively and nine inversely with regard
to what is considered effective self-care. The question-
naire allows the summation to a ‘Sum Scale’ score as
well as estimation of four subscale scores. In view of
their contents, the subscales were labelled ‘Glucose
Management’ (items 1, 4, 6, 10, 12), ‘Dietary Control’
(items 2, 5, 9, 13), ‘Physical Activity’ (items 8, 11, 15),
and ‘Health-Care Use’ (items 3, 7, 14). One item (16) re-
quests an overall rating of self-care and is to be included
in the ‘Sum Scale’ only. The full questionnaire is
displayed in Table 1.
Scoring of the questionnaire involved reversing nega-
tively worded items such that higher values are indicative
of more effective self-care. Scale scores were calculated as
sums of item scores and then transformed to a scale
Table 1 Diabetes Self-Management Questionnaire (DSMQ)
The following statements describe self-care activities related to your
diabetes. Thinking about your self-care over the last 8 weeks, please
specify the extent to which each statement applies to you.
Applies to
me very
much
Applies to me
to a consider-able
degree
Applies to
me to some
degree
Does not
apply to
me
1. I check my blood sugar levels with care and attention.
☐ Blood sugar measurement is not required as a part of my treatment.
☐3 ☐2 ☐1 ☐0
2. The food I choose to eat makes it easy to achieve optimal blood sugar levels. ☐3 ☐2 ☐1 ☐0
3. I keep all doctors’ appointments recommended for my diabetes treatment. ☐3 ☐2 ☐1 ☐0
4. I take my diabetes medication (e. g. insulin, tablets) as prescribed.
☐ Diabetes medication / insulin is not required as a part of my treatment.
☐3 ☐2 ☐1 ☐0
5. Occasionally I eat lots of sweets or other foods rich in carbohydrates. ☐3 ☐2 ☐1 ☐0
6. I record my blood sugar levels regularly (or analyse the value chart
with my blood glucose meter).
☐ Blood sugar measurement is not required as a part of my treatment.
☐3 ☐2 ☐1 ☐0
7. I tend to avoid diabetes-related doctors’ appointments. ☐3 ☐2 ☐1 ☐0
8. I do regular physical activity to achieve optimal blood sugar levels. ☐3 ☐2 ☐1 ☐0
9. I strictly follow the dietary recommendations given by my doctor or diabetes specialist. ☐3 ☐2 ☐1 ☐0
10. I do not check my blood sugar levels frequently enough as would be required for
achieving good blood glucose control.
☐ Blood sugar measurement is not required as a part of my treatment.
☐3 ☐2 ☐1 ☐0
11. I avoid physical activity, although it would improve my diabetes. ☐3 ☐2 ☐1 ☐0
12. I tend to forget to take or skip my diabetes medication (e. g. insulin, tablets).
☐ Diabetes medication / insulin is not required as a part of my treatment.
☐3 ☐2 ☐1 ☐0
13. Sometimes I have real ‘food binges’ (not triggered by hypoglycaemia). ☐3 ☐2 ☐1 ☐0
14. Regarding my diabetes care, I should see my medical practitioner(s) more often. ☐3 ☐2 ☐1 ☐0
15. I tend to skip planned physical activity. ☐3 ☐2 ☐1 ☐0
16. My diabetes self-care is poor. ☐3 ☐2 ☐1 ☐0
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score * 10; for example, for the subscale ‘Glucose Manage-
ment’ a raw score of 12 leads to a transformed score of 12
/ 15 * 10 = 8). A transformed score of ten thus represented
the highest self-rating of the assessed behaviour. If ‘not re-
quired as a part of my treatment’ had been marked in an
item, it was not used, and the scale score computation
was adapted accordingly (by reducing the theoretical max-
imum score by three points). However, in case of more
than half of the items of a scale missing, a scale score
should not be computed.
The questionnaire was translated into English using a
standardised forward and backward translation proced-
ure, as recommended by Bradley [54]. Two independent
bilingual speakers and experts in diabetes treatment
performed the forward translation. The results were
reviewed and matched by the developmental team. An
independent bilingual speaker familiar with the field
completed the backward translation. Ultimately, the back-
translated and original questionnaires were matched, and
the English version was finalised.
Summary of Diabetes Self-Care Activities Measure (SDSCA)
The SDSCA is an 11 item scale, which assesses several
self-care activities by the patient’s report on the previousweek. The respondent marks the number of days of the
week on which the indicated behaviours were
performed. The questionnaire’s first ten items are
summed to a total score and pairwise averaged to five
scale scores. The five scales are called ‘General Diet’,
‘Specific Diet’, ‘Exercise’, ‘Blood-Glucose Testing’, and
‘Foot-Care’, and represent the corresponding behaviours
(‘General Diet’ regards to a prescribed or generally help-
ful diet, whereas the items of ‘Specific Diet’ assess the
consumption of ‘fruits and vegetables’ and ‘high fat
foods’). The eleventh item regards smoking and assesses
the average number of cigarettes smoked per day.
A review of seven studies [22] reported good consist-
encies (with the exception of the scale ‘Specific diet’) as
well as adequate retest-reliability and criterion validity of
the scales: The mean inter-item-correlation of the scale
items was r = 0.47, the mean retest-correlation of scales
was r = 0.40, and the mean of criterion-related correla-
tions (estimated for ‘General Diet’, ‘Specific Diet’, and
‘Exercise’) was r = 0.23.
In this study, reliability of the SDSCA’s sum scale as de-
termined by Cronbach’s α coefficient was 0.63. For the
scales ‘General Diet’, ‘Exercise’, ‘Blood-Glucose Testing’,
and ‘Foot-Care’ coefficients between 0.69 and 0.88 were
observed. However, the scale ‘Specific Diet’ demonstrated
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of 0.15, which corresponds to the results by Toobert et al.
[22].
Glycaemic control
Glycated haemoglobin values were used as indicator of
glycaemic control. All blood samples were analysed in
the German Diabetes Center’s laboratory using high per-
formance liquid chromatography (HPLC) performed
with the Bio-Rad Variant II Turbo analyser. The period
between blood sampling and questionnaire assessment
was usually less than one week.
Statistical analyses
The analyses were performed using SYSTAT 10.2 (Systat
Software, Point Richmond, CA, USA) and SPSS 21.0.0
(SPSS Inc., Chicago, IL, USA). Group comparisons in-
volved One-way Analysis of Variance, Student’s t-test
and Pearson’s chi-squared test. In all analyses a P-value
of < 0.05 (two-tailed test) was considered as criterion of
statistical significance.
To evaluate item characteristics, item difficulty indices
(defined as percentage of agreements among all re-
sponses), inter-item-correlations and corrected item-
total-correlations were computed, and the items were
analysed for an increase of the scale’s reliability coeffi-
cient (Cronbach’s α) in case of item deletion. Addition-
ally, the items’ correlations with the HbA1c value were
analysed. To estimate the scales’ internal consistencies,
Cronbach’s α coefficients were computed. All item ana-
lyses were based on inverted item scores.
Exploratory principal component factor analysis (EFA)
was used to evaluate the scale’s content structure. In this
process, the varimax rotation was employed, as it usually
produces explicit results which can facilitate the inter-
pretation. Furthermore, it was assumed that the assessed
self-care activities do not necessarily have to be corre-
lated, which also suggests the orthogonal varimax
rotation.
Confirmatory factor analysis (CFA) was performed
using AMOS 21.0.0 to test the model defined by the
EFA as well as a single factor model using the maximal
likelihood estimation method. To evaluate the model fit,
the Chi2/df ratio, comparative fit index (CFI), root mean
square error of approximation (RMSEA), and the P-
value of close fit (PCLOSE) were analysed. Adequate
model fit is considered to be indicated by a Chi2/df ratio
< 2 [55], a CFI value ≥ 0.90 [56], a RMSEA value < 0.08,
and a PCLOSE > 0.05 [57].
To estimate the instrument’s validity, criterion-related
correlations were analysed. The criteria were the SDSCA
scales of self-care and the clinical outcomes BMI and
HbA1c. Since DSMQ scores as well as SDSCA scores
were not normally distributed, Spearman’s correlations(ρ) were used. Patient characteristics such as sex, age,
diabetes type, diabetes duration, type of medical therapy,
and number of late complications were included in the
analyses to examine possible associations (in case of the
dichotomous variables sex, diabetes type, and use of in-
sulin point-biserial correlations were estimated).
Additionally, known groups validity was assessed by
assorting the patients into three groups according to the
HbA1c value, which were then examined regarding self-
care activities as assessed by the DSMQ. Patients with
HbA1c values up to 7.5% were classified as ‘good gly-
caemic control’, patients with values between 7.6 and
8.9% were classified as ‘medium glycaemic control’, and
patients with values from 9.0% as ‘poor glycaemic con-
trol’. Between-groups differences were analysed using
One-way Analyses of Variance.
To evaluate the instrument’s utility for the prediction
of glycaemic control, the correlations of its scales with
HbA1c were compared to those of the equivalent scales
of the SDSCA. Differences were tested for statistical sig-
nificance using Steiger’s Z test of the difference between
correlated correlations, as recommended by Meng,
Rosenthal & Rubin [58].
If feasible (according to the sample sizes), the
explained analyses were additionally performed on the
basis of the diabetes type 1 and 2 subsamples in order to
test the applicability of the questionnaire in both dia-
betes types.Results
Study 1: Development of the 16 item scale
In order to perform the item selection, 110 patients were
assessed with the preliminary set of 37 items. The pa-
tients’ mean age was 51 ± 16 years, 44% were female
and the mean BMI was 30 ± 7 kg/m2. 46% were diag-
nosed with type 1 diabetes and the average duration of
the illness was 16 ± 10 years. The majority used an ex-
clusive (64%) or medication-combined insulin therapy
(22%), while only 13% used non-insulin medical treat-
ments. The mean HbA1c was 8.5 ± 1.8% and 53% of the
patients were diagnosed with one or more late
complications.
In a first step, 10 items without significant correlation
with HbA1c (two-sided P ≥ 0.05) were removed. The rele-
vant items assessed dealing with hypoglycaemic episodes,
calculation of carbohydrates, alcohol consumption, carriage
of needed therapy devices, and weight control. The
remaining 27 items showed correlations with the HbA1c
value between −0.19 and −0.43.
In a second step, two items which were found to de-
crease the internal consistency of this item selection
were removed. For the remaining 25 items an α coeffi-
cient of 0.93 was observed.
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performed. The analysis identified five factors with eigen-
values higher than 1, which explained 64% of the variance.
Varimax-rotated factor loadings were evaluated, and six
items which did not show a loading of 0.50 or higher on
any factor were removed. A renewed analysis of the
remaining 19 items revealed a four factor structure, which
still explained 61% of the variance.
In a fourth step, the factors were interpreted and the
matching of items was rated. The factors could be easily
interpreted as ‘dietary habits’, ‘blood glucose measurement/
medication intake’, ‘contact with health-care professionals’,
and ‘physical activity’. Regarding the associated items, there
were three significant deviations: Firstly, one item which
asks for overall self-care loaded primarily on ‘dietary habits’
(0.67). It was removed consequently. Secondly, one item
which asks for the recording of blood glucose levels
showed indeed a loading of 0.44 on the ‘blood glucose
measurement/ medication intake’ factor, but it was primar-
ily related to ‘contact with health-care professionals’ (0.61).
Despite its bidimensionality and with a view to its correl-
ation with HbA1c of 0.38, it was decided to keep the item.
Thirdly, one item showed substantial loadings (> 0.30) on
all four factors. As this item regards overall self-care (‘my
diabetes self-care is poor’), the pattern of factor loadings
was rated to indicate an appropriate matching.
In the final step, the remaining 18 items were analysed for
contentual redundancy. Among the items of ‘medication in-
take’ and ‘dietary habits’, there were each two items of
equivalent content and equal connotation. In each case, the
item with the lower correlation with HbA1c was removed.
According to the structure and its contents, four sub-
scales were identified and labelled ‘Glucose Manage-
ment’ (five items), ‘Dietary Control’ (four items), ‘Physical
Activity’ (three items), and ‘Health-Care Use’ (three
items). One additional item which addresses overall self-
care (‘my diabetes self-care is poor’) is included in the
‘Sum Scale’ only (16 items).
Study 2: Evaluation of the 16 item scale
The psychometric properties of the final 16 item version
of the DSMQ were assessed in 261 patients. The SDSCA
served as comparison to assess the quality of our scale.
The sample characteristics are presented in Table 2. The
sample was generally well matched to the first study’s
sample, except that 58% of the patients were diagnosed
with type 1 diabetes, which is 12% more than in the first
study. However, with an average age of 52 ± 15 years, 44%
female sex, a mean BMI of 30 ± 7 kg/m2, and a mean
HbA1c value of 8.6 ± 1.5% in this study, the two samples
were highly comparable. Despite the slightly different pro-
portions of diabetes types, rates of specific treatments,
mean diabetes durations, and late complication statuses
were highly similar (as can be seen in Table 2).Item characteristics and reliability
Item analyses revealed a mean item difficulty of 46.7 (SD
= 25.5). However, the indices of items 3, 4, and 7 were lo-
cated in the peripheral zones of the distribution. The
mean inter-item-correlation (or homogeneity) was 0.25
(SD = 0.15). The mean item-subscale-correlations were
0.56 (SD = 0.09) for ‘Glucose Management’, 0.57 (SD =
0.05) for ‘Dietary Control’, 0.59 (SD = 0.10) for ‘Physical
Activity’, and 0.43 (SD = 0.01) for ‘Health-Care Use’. For
the ‘Sum Scale’ a mean item-total-correlation of 0.46 (SD
= 0.12) was observed, and in no case an item deletion led
to an increase of the scale’s α coefficient (see Table 3).
Two items (14, 15), however, showed item-total-correla-
tions lower than 0.30. Still, those were highly correlated
with their corresponding subscales. All items were nega-
tively related to HbA1c with a mean correlation of −0.23
(SD = 0.09). With the exception of the items 8 and 15,
both on physical activity, all correlations with HbA1c were
significant. A detailed overview of the above item charac-
teristics is displayed in Table 3.
Reliability analyses revealed good internal consistency
of the ‘Sum Scale’ and acceptable consistencies of the
subscales (except the subscale ‘Health-Care Use’ which
showed a marginal consistency value). Cronbach’s α co-
efficients were 0.77 for ‘Glucose Management’, 0.77 for
‘Dietary Control’, 0.76 for ‘Physical Activity’, and 0.60 for
‘Health-Care Use’. For the ‘Sum Scale’ an α coefficient of
0.84 was observed.
If item and scale properties were assessed in the dia-
betes type subsamples separately, the analyses collect-
ively revealed comparable results. In type 1 diabetes
patients, the mean inter-item-correlation was 0.30 (SD =
0.14), the mean item-subscale-correlation was 0.58 (SD
= 0.07), and the mean item-total-correlation was 0.51
(SD = 0.11). All items showed negative associations with
HbA1c with a mean correlation of −0.25 (SD = 0.11),
and with the exception of items 8, 11, and 15 all coeffi-
cients were significant. The DSMQ subscales showed α
coefficients of averagely 0.76 (SD = 0.05) and the ‘Sum
Scale’s α was 0.87.
In type 2 patients, the mean inter-item-correlation was
0.20 (SD = 0.17), the mean item-subscale-correlation was
0.50 (SD = 0.12), and the mean item-total-correlation was
0.40 (SD = 0.16). All items were negatively related to the
HbA1c value with a mean correlation of −0.22 (SD = 0.09).
However, in five cases (items 8, 9, 11, 14, and 15) the cor-
relations were insignificant. The DSMQ scales’ α coeffi-
cients were averagely 0.68 (SD = 0.12) for the four
subscales and 0.80 for the ‘Sum Scale’.
Factorial validity
EFA suggested a four factor structure according to the
Kaiser-Guttman criterion explaining 60% of variance.
This result was supported by the scree test. The varimax
Table 2 Characteristics of the study sample
Total Type 1 DM Type 2 DM P-valuea
N = 261 n = 150 (57.5%) n = 111 (42.5%)
Female gender 110 (42.1%) 68 (45.3%) 42 (37.8%) 0.225
Age (years) 52.0 ± 14.9 45.8 ± 14.8 60.4 ± 10.2 <0.001
BMI (kg/m2) 29.7 ± 6.9 26.3 ± 4.7 34.4 ± 6.6 <0.001
Diabetes duration (years) 17.5 ± 10.4 19.0 ± 11.2 15.3 ± 8.8 0.003
Insulin therapyb 241 (92.3%) 150 (100%) 91 (82%) <0.001
Exclusively insulin 186 (71.3%) 147 (98%) 39 (35.1%) <0.001
Combined with medicationc 55 (21.1%) 3 (2%) 52 (46.8%) <0.001
Non-insulin medical therapyc 20 (7.7%) 0 (0%) 20 (18%) <0.001
With late complication(s)d 132 (50.6%) 56 (37.3%) 76 (68.5%) <0.001
Number per concerned persond 1.8 ± 1.1 1.4 ± 0.9 2.1 ± 1.1 <0.001
HbA1c value (%) 8.6 ± 1.5 8.4 ± 1.4 8.8 ± 1.7 0.070
DSMQ ‘Sum Scale’ 6.8 ± 1.7 6.9 ± 1.7 6.6 ± 1.6 0.121
Subscale ‘Glucose Management’ 7.5 ± 2.3 7.5 ± 2.3 7.5 ± 2.3 0.959
Subscale ‘Dietary Control’ 5.4 ± 2.4 5.2 ± 2.4 5.7 ± 2.4 0.146
Subscale ‘Physical Activity’ 5.8 ± 2.7 6.5 ± 2.6 4.8 ± 2.6 <0.001
Subscale ‘Health-Care Use’ 8.3 ± 1.9 8.5 ± 1.9 8.1 ± 2.0 0.085
Data are n (%) or M ± SD.
BMI, Body Mass Index; HbA1c, glycated haemoglobin; DSMQ, Diabetes Self-Management Questionnaire; M, mean; SD, standard deviation.
a regards differences between diabetes types; Student’s t-Test or Chi2-Test (two-tailed test).
b any type of diabetes therapy which includes the use of insulin.
c oral antidiabetic agents and/or incretin mimetics.
d retinopathy, neuropathy, nephropathy, diabetic foot, and/or arterial occlusive disease.
Table 3 Distribution of scores, item difficulties, scale-correlations, internal consistency in case of deletion, and
correlations with HbA1c of the DSMQ items
Item Distribution of item
scores
Difficulty
indexa
Item-subscale-
correlationb
Item-total-
correlationb
α if item
deleted
Correlation with
HbA1c
1 2.28 ± 0.90 78.9 0.69 0.59 0.82 −0.35‡
2 1.56 ± 0.82 53.3 0.58 0.62 0.82 −0.28‡
3 2.68 ± 0.65 94.3 0.42 0.32 0.83 −0.20†
4 2.76 ± 0.55 96.2 0.53 0.49 0.83 −0.27‡
5 1.62 ± 1.04 45.2 0.62 0.46 0.83 −0.17†
6 1.97 ± 1.12 65.9 0.49 0.47 0.83 −0.24‡
7 2.67 ± 0.63 6.5 0.44 0.35 0.83 −0.19†
8 1.36 ± 0.93 44.4 0.52 0.39 0.83 −0.09
9 1.43 ± 0.85 43.7 0.60 0.51 0.82 −0.16†
10 1.99 ± 1.07 31.4 0.60 0.55 0.82 −0.33‡
11 2.04 ± 1.01 31.4 0.70 0.41 0.83 −0.15*
12 2.31 ± 0.96 19.5 0.48 0.40 0.83 −0.30‡
13 1.91 ± 1.04 36.4 0.50 0.50 0.82 −0.30‡
14 2.15 ± 0.98 26.8 0.43 0.26 0.84 −0.20†
15 1.83 ± 1.03 38.7 0.55 0.28 0.84 −0.11
16 1.91 ± 1.01 33.7 n/a 0.69 0.81 −0.38‡
Data are M ± SD, difficulty indices, Pearson’s correlations, Cronbach’s α or Spearman’s ρ.
Correlations with HbA1c are Spearman’s ρ; * P < 0.05; † P < 0.01; ‡ P < 0.001 (two-tailed test).
a percentage of agreements among all responses.
b part-whole-corrected.
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factor loadings the factors represented the contents of
‘effective blood glucose measurement and medication in-
take’ (items 1, 4, 6, 10, 12), ‘dietary habits facilitating dia-
betes control’ (items 2, 5, 9, 13), ‘avoidance of physical
exercise’ (items 8, 11, 15), and ‘avoidance of medical ap-
pointments’ (items 3, 7, 14). Item 6, which asks for the
recording of blood glucose levels, again (as in the first
study) revealed a bidimensional structure with its add-
itional loading on the diet factor. The global item 16
loaded substantially (≥ 0.30) on all factors except ‘avoid-
ance of medical appointments’. The factor loadings are
presented in Table 4.
To test the observed factor structure, all items except
item 16 were aggregated to four correlated factors (as
suggested by the EFA) using CFA. The analysis revealed
the following model fit indices: The Chi2/df ratio was
1.64, the CFI value was 0.96, the RMSEA value was 0.05,
and the PCLOSE was 0.50. These results indicate a very
appropriate fit of the four factor model. To evaluate the
feasibility of integrating all items to a total scale, an add-
itional single factor model (all 16 items aggregated on
one factor) was tested. The analysis revealed a Chi2/df
ratio of 1.74, a CFI value of 0.95, a RMSEA value was
0.053, and a PCLOSE of 0.34, which indicated an ad-
equate fit of this model, too.
Known-groups validity
The comparison of patient groups with ‘good glycaemic
control’ (HbA1c ≤ 7.5%), ‘medium glycaemic control’Table 4 Rotated factor loadings of the DSMQ items
Items
1 Check blood sugar levels with care and attention
4 Take diabetes medication as prescribed
6 Record blood sugar levels regularly
10 Do not check blood sugar levels frequently enough
12 Forget to take/ skip diabetes medication
2 Choose food to easily achieve optimal blood sugar
5 Occasionally eat lots of sweets/ high-carb foods
9 Follow specialist’s dietary recommendations
13 Sometimes have real ‘food binges’
8 Do physical activity to achieve optimal sugar levels
11 Avoid physical activity, although good for diabetes
15 Skip planned physical activity
3 Keep recommended doctors’ appointments
7 Avoid diabetes-related doctors’ appointments
14 Should see medical practitioner(s) more often
16 Diabetes self-care is poor
Extraction method: Principal component analysis. Rotation method: Varimax.
Items are shortened for ease of presentation; related factor loadings are printed in(HbA1c 7.6 – 8.9%), and ’poor glycaemic control’ (HbA1c
≥ 9.0%) revealed significant differences regarding both
the DSMQ sum scores as well as the subscale scores. All
results are shown in Table 5.
According to these results, patients with ‘good gly-
caemic control’ reported significantly more ‘Glucose
Management’, ‘Dietary Control’, ‘Physical Activity’, and
‘Health-Care Use’ than those with ‘poor control’. Corres-
pondingly, in this group the mean ‘Sum Scale’ score was
significantly higher.
Compared to the ‘medium glycaemic control’ group,
patients with ‘good control’ reported significantly more
‘Glucose Management’ and ‘Physical Activity’. Further-
more, they had a higher ‘Sum Scale’ score than those
with ‘medium control’. However, significant differences
regarding ‘Dietary Control’ and ‘Health-Care Use’ were
not observed.
Patients with ‘medium glycaemic control’, on the other
hand, reported significantly more ‘Glucose Management’
and ‘Dietary Control’ than those with ‘poor control’, and
they also had a higher ‘Sum Scale’ score. However, no
significant differences were observed regarding ‘Physical
Activity’ and ‘Health-Care Use’.Convergent validity
The DSMQ’s associations with external criteria (patient
characteristics, BMI, SDSCA scales, and HbA1c value) as
observed in the total sample as well as the diabetes type
specific subsamples are presented in Table 6.Factor 1 Factor 2 Factor 3 Factor 4
0.72 0.34 0.00 −0.10
0.67 0.16 −0.02 −0.19
0.50 0.44 0.18 −0.22
−0.76 −0.12 0.18 0.14
−0.76 0.01 0.08 0.03
0.32 0.71 −0.14 −0.11
−0.10 −0.79 0.02 0.02
0.12 0.79 −0.12 −0.02
−0.10 −0.59 0.29 0.17
0.13 0.31 −0.67 0.14
−0.10 −0.12 0.87 0.05
0.02 −0.00 0.82 0.12
0.12 0.12 −0.01 −0.71
−0.15 −0.14 0.02 0.70
−0.13 0.03 0.05 0.77
−0.48 −0.43 0.35 0.23
bold.
Table 5 Comparison of the DSMQ self-care activities in patients with HbA1c ≤ 7.5%, from 7.6 to 8.9%, and ≥ 9.0%
DSMQ HbA1c ≤ 7.5% Sign.
a HbA1c 7.6–8.9% Sign.
b HbA1c ≥ 9.0% Sign.
c ANOVA
self-care activities (n = 67) (n = 106) (n = 88) P-value
Glucose Management 8.7 ± 1.6 * 7.8 ± 2.0 ‡ 6.4 ± 2.5 ‡ <0.001
Dietary Control 6.4 ± 2.1 ns 5.6 ± 2.3 † 4.5 ± 2.4 ‡ <0.001
Physical Activity 6.6 ± 2.7 * 5.5 ± 2.7 ns 5.5 ± 2.6 * 0.021
Health-Care Use 8.7 ± 1.6 ns 8.5 ± 1.9 ns 7.9 ± 2.1 * 0.013
Sum Scale 7.7 ± 1.2 † 6.9 ± 1.4 ‡ 5.9 ± 1.8 ‡ <0.001
Data are M ± SD. Tests were One-way ANOVA and Scheffé Test for post-hoc group comparisons. Scheffé Test significance is expressed: * P < 0.05; † P < 0.01; ‡ P <
0.001; ns, not significant.
DSMQ, Diabetes Self-Management Questionnaire; HbA1c, glycated haemoglobin; ANOVA, Analysis of Variance.
a regards comparison between the first and second group.
b regards comparison between the second and third group.
c regards comparison between the third and first group.
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total sample of 261 patients revealed the following re-
sults: The subscale ‘Glucose Management’ was highly
correlated with the equivalent SDSCA scale ‘Blood-Glu-
cose Testing’ (ρ = 0.57) and the HbA1c value (ρ = −0.39).
The subscale ‘Dietary Control’ was highly correlated
with the equivalent SDSCA scale ‘General Diet’
(ρ = 0.52) and substantially with ‘Specific Diet’
(ρ = 0.28). Furthermore, it showed a substantial negative
correlation with HbA1c (ρ = −0.30). The subscale ‘Phys-
ical Activity’ was highly correlated with the equivalent
SDSCA scale ‘Exercise’ (ρ = 0.58). Its correlation with
the HbA1c value was −0.15 and there was also a high
negative correlation with the BMI (ρ = −0.41). Regarding
the subscale ‘Health-Care Use’ there is no equivalent
scale of the SDSCA. Nevertheless, it was significantly
correlated with the SDSCA scales ‘General Diet’ (ρ =
0.13), ‘Blood-Glucose Testing’ (ρ = 0.26), ‘Foot Care’ (ρ =
0.10), and ‘Smoking’ (ρ = −0.19), and showed a substan-
tial negative correlation with the HbA1c value of −0.22.
Finally, the DSMQ ‘Sum Scale’ showed substantial to
high correlations between 0.20 and 0.51 with all SDSCA
scales and was highly correlated with the SDSCA’s total
score with 0.57. Its negative correlation with the HbA1c
value was high (ρ = −0.40).
If convergent correlations were assessed separately by
diabetes type, the analyses of both subsamples revealed
results which were highly comparable to those presented
above. All DSMQ subscales as well as the ‘Sum Scale’
still showed significant correlations of equivalent sizes
with their relevant convergent criteria (see Table 6).
However, one exception was observed regarding the
subscale ‘Physical Activity’: Although it showed slight
correlations with HbA1c in both types of diabetes pa-
tients, none of those reached statistical significance.
DSMQ vs. SDSCA: Associations with HbA1c
The comparison between the DSMQ scales and their
equivalent SDSCA scales regarding the correlations withHbA1c (and for the physical activity scales with BMI) re-
vealed the following results:
As in the case with the DSMQ subscale ‘Glucose Man-
agement’, the SDSCA’s equivalent scale ‘Blood-Glucose
Testing’ was significantly correlated with the HbA1c
value (ρ = −0.22, P < 0.001). However, the correlation
between ‘Glucose Management’ and HbA1c (ρ = −0.39,
P < 0.001) was significantly higher (Z = −3.07, P < 0.01).
While the SDSCA scale ‘Specific Diet’ was not corre-
lated with HbA1c (ρ = −0.02, P = 0.746), the scale ‘Gen-
eral Diet’ was (ρ = −0.13, P = 0.042). However, the
DSMQ subscale ‘Dietary Control’ showed a higher cor-
relation (ρ = −0.30, P < 0.001), and again the difference
was significant (Z = −2.84, P < 0.01).
In contrast to the DSMQ subscale ‘Physical Activity’
(ρ = −0.15, P = 0.013), the equivalent SDSCA scale ‘Ex-
ercise’ was not correlated with HbA1c (ρ = 0.07,
P = 0.239), and the difference between correlations was
significant (Z = −3.96, P < 0.001). Additionally, ‘Physical
Activity’ showed a higher correlation with the BMI
(ρ = −0.41, P < 0.001) than the SDSCA scale ‘Exercise’
(ρ = −0.18, P = 0.004), and this difference again was sig-
nificant (Z = −4.33, P < 0.001).
In contrast to the DSMQ ‘Sum Scale’, which showed a
notable correlation with the HbA1c value of −0.40
(P < 0.001), the SDSCA’s total score was not significantly
correlated with HbA1c (ρ = −0.10, P = 0.123). This dif-
ference was highly significant (Z = −5.39, P < 0.001).
When these correlational analyses were performed
separately by diabetes type, the results were in total
clearly consistent with the ones described above. In both
diabetes types the DSMQ scales ‘Glucose Management’,
‘Dietary Control’ and ‘Sum Scale’ showed significantly
higher correlations with HbA1c than their equivalent
SDSCA scales (all P < 0.05). However, neither the
DSMQ subscale ‘Physical Activity’ nor its equivalent ‘Ex-
ercise’ were significantly correlated with HbA1c in the
subsamples (all P > 0.10). Therefore, the finding of a
higher association between the DSMQ subscale and
Table 6 Correlations between the DSMQ scales and patient characteristics, SDSCA scales, and HbA1c as assessed in the
total sample and type 1 (in parenthesis) and type 2 (in square brackets) diabetes patient subgroups
DSMQ
Glucose Management Dietary Control Physical Activity Health-Care Use Sum Scale
Female gender 0.03 −0.03 −0.00 0.09 0.01
(−0.07) (−0.00) (0.06) (0.11) (0.00)
[0.18] [−0.06] [−0.15] [0.05] [0.02]
Age 0.32‡ 0.40‡ −0.05 0.12* 0.28‡
(0.44‡) (0.41‡) (0.16*) (0.27†) (0.44‡)
[0.27†] [0.36‡] [0.05] [0.15] [0.31†]
BMI 0.00 −0.07 −0.41‡ −0.08 −0.22‡
(0.03) (−0.11) (−0.30‡) (0.01) (−0.15)
[−0.08] [−0.23†] [−0.27†] [−0.06] [−0.25†]
Diabetes type 1 −0.00 −0.09 0.31‡ 0.11 0.10
(−) (−) (−) (−) (−)
[−] [−] [−] [−] [−]
Diabetes duration 0.10 0.02 0.09 0.15* 0.13*
(0.12) (−0.02) (0.07) (0.12) (0.08)
[0.07] [0.13] [0.01] [0.18] [0.18]
Insulin therapya 0.09 0.02 0.03 0.05 0.08
(−0.09) (−0.05) (−0.04) (0.13) (−0.05)
[0.17] [0.10] [−0.10] [−0.00] [0.10]
Number of late complicationsb 0.05 0.24‡ −0.14* 0.01 0.08
(0.09) (0.07) (−0.06) (0.12) (0.07)
[0.02] [0.37‡] [0.03] [−0.03] [0.22†]
SDSCA Blood-Glucose Testing 0.57‡ 0.28‡ 0.24‡ 0.26‡ 0.51‡
(0.58‡) (0.37‡) (0.29‡) (0.28‡) (0.56‡)
[0.58‡] [0.25†] [0.09] [0.19*] [0.44‡]
SDSCA General Diet 0.29‡ 0.52‡ 0.18† 0.13* 0.44‡
(0.38‡) (0.55‡) (0.29‡) (0.26†) (0.54‡)
[0.20*] [0.44‡] [0.17] [−0.03] [0.36‡]
SDSCA Specific Diet 0.08 0.28‡ 0.19† 0.08 0.24‡
(0.01) (0.28‡) (0.20*) (0.22†) (0.26†)
[0.16] [0.26†] [0.23†] [−0.09] [0.23]
SDSCA Exercise 0.05 0.17† 0.58‡ 0.06 0.30‡
(0.09) (0.22†) (0.60‡) (0.10) (0.35‡)
[−0.01] [0.12] [0.53‡] [−0.02] [0.18]
SDSCA Foot-Care 0.25‡ 0.35‡ 0.03 0.10 0.29‡
(0.23) (0.25†) (0.19*) (0.16) (0.31‡)
[0.30†] [0.44‡] [0.05] [0.10] [0.39‡]
SDSCA Smokingc −0.22‡ −0.15* −0.09 −0.19† −0.20†
(−0.31‡) (−0.23†) (−0.22†) (−0.29†) (−0.32‡)
[−0.06] [0.04] [−0.03] [−0.09] [−0.02]
SDSCA Sum scale 0.37‡ 0.54‡ 0.39‡ 0.17† 0.57‡
(0.35‡) (0.55†) (0.51‡) (0.29†) (0.62‡)
[0.38‡]] [0.49‡] [0.34‡] [0.02] [0.51‡]
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Table 6 Correlations between the DSMQ scales and patient characteristics, SDSCA scales, and HbA1c as assessed in the
total sample and type 1 (in parenthesis) and type 2 (in square brackets) diabetes patient subgroups (Continued)
HbA1c value −0.39‡ −0.30‡ −0.15* −0.22‡ −0.40‡
(−0.44‡) (−0.31‡) (−0.12) (−0.20*) (−0.39‡)
[−0.33‡] [−0.33‡] [−0.11] [−0.21*] [−0.38‡]
Coefficients are Spearman’s ρ or point-biserial correlation (regards the dichotomous variables female sex, diabetes type 1, and insulin therapy); * P < 0.05; †
P < 0.01; ‡ P < 0.001 (two-tailed test).
Coefficients which represent type 1 patients (n = 150) are presented in parenthesis; coefficients which represent type 2 patients (n = 111) are presented in square
brackets; coefficients which are indicative of convergent validity are printed in bold.
DSMQ, Diabetes Self-Management Questionnaire; BMI, Body Mass Index; SDSCA; Summary of Diabetes Self-Care Activities Measure; HbA1c, glycated haemoglobin.
a any type of diabetes therapy which includes the use of insulin.
b retinopathy, neuropathy, nephropathy, diabetic foot, and/or arterial occlusive disease.
c average number of cigarettes smoked per day.
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replicated. Nevertheless, comparably to the total sample
evaluation, ‘Physical Activity’ showed higher correlations
with the BMI than the SDSCA scale ‘Exercise’ in both
subsamples. However, only in the type 2 patients sample
reached this difference statistical significance (Z = −2.20,
P < 0.05).
Discussion and conclusions
The purpose of this investigation was to describe the de-
velopment of the DSMQ (study 1) and evaluate its psy-
chometric properties (study 2). The questionnaire was
developed on a broad theoretical and empirical basis,
and its evaluation indicates very good psychometric
properties with adequate item characteristics, satisfac-
tory reliability, and good validity.
According to the generally satisfactory item properties
and good item validity coefficients regarding HbA1c the
overall item selection appears very satisfying. Since the
items assess a number of different aspects of self-care,
the total scale is rather heterogeneous, which is reflected
by the mean inter-item-correlation of 0.25. Against this
background and with a view to the rather low number of
items on each content, the internal consistency can be
appraised as good (based on the standard by Nunnally
and Bernstein [59]). For a polydimensional construct a
higher alpha coefficient might even be unfavourable, for
it suggests high item redundancy in the scale, as pointed
out by Streiner [60]. The slightly lower item-total-corre-
lations in two cases should be interpreted with a view to
this aspect as well. The additional analyses of the sub-
samples revealed slightly better item properties and
consistency in type 1 patients which can be partly attrib-
uted to the difference in sample size. In sum, all coeffi-
cients were in the acceptable range and suggest general
applicability.
The EFA revealed a simple structure of four factors
with high loadings of all items thereon. The factors were
well interpretable and their contents clearly confirmed
the designed scales. One discrepancy could be seen in
item 6, which belongs to the subscale ‘GlucoseManagement’ but showed an additional loading on the
dietary factor. But apart from that, the overall content
structure is remarkably clear and indicates a good factor-
ial validity. The EFA revealed a very good fit of the sug-
gested four factor model, which also confirms the
designed scales. Additionally, a single factor model was
found to fit the data as well, which suggests the feasibil-
ity of the integration of all item scores to the ‘Sum
Scale’.
The criterion-related correlations between the DSMQ
scales and the SDSCA scales indicate a good conver-
gence between parallel measures suggesting validity. The
finding that all parallel scales show a strong convergence
(> 0.5) has to be stressed particularly because the ques-
tionnaires employ markedly different time frames (one
week in the SDSCA in contrast to eight weeks in the
DSMQ) which might actually discount those correla-
tions. Additionally, the throughout significant correla-
tions with the objective outcome measure HbA1c
confirm the assumption of validity and, moreover, prove
the questionnaire’s high utility for the intended scientific
but also clinical purposes. The additional analyses of
convergent correlations by diabetes type revealed com-
parably strong associations with external criteria in both
type 1 and type 2 diabetes and provide good evidence of
the DSMQ’s general applicability.
The known groups analysis showed significant differ-
ences between patient groups with ‘good’, ‘medium’, and
‘poor’ glycaemic control, which provides evidence of the
questionnaire’s ability to discriminate between patients’
behaviours. According to these results, higher sum
scores as well as subscale scores of the DSMQ allow to
infer better self-care activities in view of glycaemic
control.
Notably, the DSMQ and SDSCA are equivalent in the
way that both questionnaires assess self-care activities,
which in most cases are clearly related, as reflected by
the correlations between the parallel scales. However, in
spite of this commonality, self-care as assessed by the
DSMQ is more strongly associated with glycated haemo-
globin, which can be explained by the differently
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more, the DSMQ’s timeframe focusses the relevant be-
haviours of the previous two months which apparently
allows a more reliable assessment of self-care and a bet-
ter prediction of the glycaemic outcome.
In the course of the item selection only self-care activ-
ities which showed relevant associations with glycaemic
control were kept. For this reason, several specific self-
care activities which may be of interest in regards of dia-
betes care are not covered by the DSMQ. However, the
precise choice of contents is essential to ensure the
questionnaire’s focus on self-care predictive of glycaemic
control. It sum, it can be stated that the DSMQ’s devel-
opment, particularly with a view to its specific objectives,
appears clearly successful.
The main limitation of the studies is based on the
composition of the samples. Both samples were drawn
from in-patients at a tertiary referral centre for diabetes,
where patients are usually hospitalized because of rele-
vant problems of diabetes treatment and glycaemic con-
trol (reflected by the average HbA1c values of 8.5 and
8.6% in the samples), and showed a relatively long aver-
age diabetes duration and a high prevalence of late com-
plications. Therefore, the study participants cannot be
rated as representative of the general diabetic popula-
tion, which limits the generalizability of results [61]. Fur-
thermore, the majority of patients was treated with
insulin, whereas only a small percentage used non-
insulin medical treatments. Thus, the pattern of correla-
tions between the DSMQ scales and HbA1c might differ
when assessed in patients not treated with insulin or
antidiabetic medication (for example, dietary aspects and
physical activity then might have a larger impact on gly-
caemic control). For this reason, the properties demon-
strated here should primarily be attributed to the
questionnaire’s use in insulin-treated patients, for the
present. However, with the exception of ‘medication in-
take’ (which is obviously related to medical regimens) all
contents assessed by the DSMQ can be literarily related
to glycaemic control regardless of the type of treatment
[34,40,45-47,51]. Finally, although a wide spectrum of
adult ages was covered in study 2 (from 18 to 86 years),
data on the questionnaire’s use in youths or children are
not available yet, suggesting further research in this
regard.
Due to the generally short length of stay at the GDCM,
the investigation was carried out cross-sectionally. Since
no retest was performed, there is no information on the
instrument’s stability or sensitivity to change. Further-
more, information on the questionnaire’s relations to com-
mon behavioural and psychological variables associated
with diabetes care is currently still limited. In these
regards additional analyses are needed. Nevertheless, the
present results may be judged as promising.The strengths of this investigation, on the other hand,
lie in the theoretical and empirical basis of the question-
naire contents on recent results from self-care research,
which facilitates the integration of our findings and sup-
ports face validity. The questionnaire development was
performed through a highly formal process of item and
test analysis (study 1), and its initial validation (study 2)
was based on a very appropriate sample size. Further-
more a high accuracy of HbA1c analysis was achieved
(due to standardised analysis in a central laboratory),
and the coincidence of blood sampling and psychomet-
ric assessment as well as the standardized data assess-
ment ensure the internal validity of results.
Regarding its associations with HbA1c, the DSMQ
showed significant superiority to the German version of
the SDSCA. It could be argued that the SDSCA’s lower
correlations were the consequence of translation prob-
lems. However, already the original English version’s ini-
tial evaluation could not relate any of its scales with
glycated haemoglobin [19], and this result is supported
by studies from several countries, which did not find sig-
nificant associations of the SDSCA scales with HbA1c ei-
ther [62-65]. Against this background, the present
findings appear conclusive, suggesting that the DSMQ’s
superiority may be attributed to the differences of con-
struct assessment between the instruments.
In sum, in this initial study the DSMQ demonstrated
very good psychometric properties. The questionnaire
presents itself as an efficient instrument which provides
reliable and valid information on diabetes self-care, and
assesses four well-defined specific self-care activities as-
sociated with glycaemic control. It was designed espe-
cially to enable scientific studies of psychosocial barriers
to self-care and glycaemic control. However, since good
metabolic control can be regarded as the most important
goal of diabetes treatment, the questionnaire appears
also valuable for the clinical use as a screener or as diag-
nostic instrument to assess barriers of glycaemic control
in individuals. Thus, the DSMQ should benefit future re-
search and also be of value in clinical settings.
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